Nelfinavir: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk m (→External Links) |
imported>David E. Volk (Chem infobox) |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
[[Image:Nelfinavir structure.jpg|right|thumb|250px|{{#ifexist:Template:Nelfinavir structure.jpg/credit|{{Nelfinavir structure.jpg/credit}}<br/>|}}Nelfinavir, a protease inhibitor.]] | |||
{{Chem infobox | |||
|align=right | |||
|image=[[Image:Nelfinavir structure.jpg|right|thumb|250px|{{#ifexist:Template:Nelfinavir structure.jpg/credit|{{Nelfinavir structure.jpg/credit}}<br/>|}}Nelfinavir, a protease inhibitor.]] | |||
|width=250px | |||
|molname=nelfinavir | |||
|synonyms= NF, NLF | |||
|molformula= C<sub>32</sub>H<sub>45</sub>N<sub>3</sub>O<sub>4</sub>S | |||
|molmass= 567.7824 | |||
|uses=HIV | |||
|properties=protease inhibitor | |||
|hazards=see drug interactions | |||
|iupac= see chemistry section | |||
|casnumber= 159989-64-7 | |||
}} | |||
'''Nelfinavir''', sometimes abbreviated as '''NFV''' or '''NLF''' and sold under the brand name '''Viracept®''' is a [[protease inhibitor]] used to treat [[HIV]]/[[AIDS]]. Nelfinavir binds to and inhibits the HIV-1 viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in non-infectious, immature viral particles. Its short half-life (3.5-5 hr) and the lack of activity of it major metabolites means that nelfinavir must be taken every 4-5 hours. It most often used in combination with two or more anti-HIV drugs. | '''Nelfinavir''', sometimes abbreviated as '''NFV''' or '''NLF''' and sold under the brand name '''Viracept®''' is a [[protease inhibitor]] used to treat [[HIV]]/[[AIDS]]. Nelfinavir binds to and inhibits the HIV-1 viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in non-infectious, immature viral particles. Its short half-life (3.5-5 hr) and the lack of activity of it major metabolites means that nelfinavir must be taken every 4-5 hours. It most often used in combination with two or more anti-HIV drugs. | ||
Revision as of 08:32, 22 March 2008
|
| |||||||
| nelfinavir | |||||||
| |||||||
| Uses: | HIV | ||||||
| Properties: | protease inhibitor | ||||||
| Hazards: | see drug interactions | ||||||
| |||||||
Nelfinavir, sometimes abbreviated as NFV or NLF and sold under the brand name Viracept® is a protease inhibitor used to treat HIV/AIDS. Nelfinavir binds to and inhibits the HIV-1 viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in non-infectious, immature viral particles. Its short half-life (3.5-5 hr) and the lack of activity of it major metabolites means that nelfinavir must be taken every 4-5 hours. It most often used in combination with two or more anti-HIV drugs.
Its chemical name is (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino] -4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide, and its chemical formula is C32H45N3O4S.
External Links
- Nelfinavir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank